Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.

Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Leibowitz MR.

Arch Gen Psychiatry. 1989 Dec;46(12):1080-7.

PMID:
2686575
3.

Chronic depression: response to placebo, imipramine, and phenelzine.

Stewart JW, McGrath PJ, Quitkin FM, Rabkin JG, Harrison W, Wager S, Nunes E, Ocepek-Welikson K, Tricamo E.

J Clin Psychopharmacol. 1993 Dec;13(6):391-6.

PMID:
8120152
4.

A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.

Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, Tricamo E.

Int J Eat Disord. 1994 Jan;15(1):1-9.

PMID:
8124322
5.

Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.

Quitkin FM, Harrison W, Stewart JW, McGrath PJ, Tricamo E, Ocepek-Welikson K, Rabkin JG, Wager SG, Nunes E, Klein DF.

Arch Gen Psychiatry. 1991 Apr;48(4):319-23.

PMID:
2009033
6.

Antidepressant specificity in atypical depression.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF.

Arch Gen Psychiatry. 1988 Feb;45(2):129-37.

PMID:
3276282
7.

Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.

Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF.

Arch Gen Psychiatry. 1989 Sep;46(9):787-93.

PMID:
2673130
8.

A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.

McGrath PJ, Stewart JW, Nunes EV, Ocepek-Welikson K, Rabkin JG, Quitkin FM, Klein DF.

Am J Psychiatry. 1993 Jan;150(1):118-23.

PMID:
8417553
9.

Phenelzine v imipramine in atypical depression. A preliminary report.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.

Arch Gen Psychiatry. 1984 Jul;41(7):669-77.

PMID:
6375621
10.

Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.

Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Tricamo E, Wager SG, Ocepek-Welikson K, Nunes E, Rabkin JG, Klein DF.

Arch Gen Psychiatry. 1990 Oct;47(10):935-41.

PMID:
2222132
11.

Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.

Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG.

Am J Psychiatry. 1988 Mar;145(3):306-11.

PMID:
3278631
12.

Can mildly depressed outpatients with atypical depression benefit from antidepressants?

Stewart JW, McGrath PJ, Quitkin FM.

Am J Psychiatry. 1992 May;149(5):615-9.

PMID:
1575250
13.

Predictive value of symptoms of atypical depression for differential drug treatment outcome.

McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, Wager SG, Tricamo E, Quitkin FM, Klein DF.

J Clin Psychopharmacol. 1992 Jun;12(3):197-202.

PMID:
1629387
14.

Psychopharmacologic validation of atypical depression.

Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin JG, Tricamo E, Markowitz JS, Klein DF.

J Clin Psychiatry. 1984 Jul;45(7 Pt 2):22-5.

PMID:
6376483
15.

Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.

Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.

Br J Psychiatry Suppl. 1993 Sep;(21):30-4.

PMID:
8217065
16.

Efficacy in long-term treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1996;57 Suppl 2:24-30. Review.

PMID:
8626360
17.

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, Risser RC.

Arch Gen Psychiatry. 1999 May;56(5):431-7.

18.

Phenelzine for chronic depression: a study of continuation treatment.

Harrison W, Rabkin J, Stewart JW, McGrath PJ, Tricamo E, Quitkin F.

J Clin Psychiatry. 1986 Jul;47(7):346-9.

PMID:
3522558
19.

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.

Kosten TR, Frank JB, Dan E, McDougle CJ, Giller EL Jr.

J Nerv Ment Dis. 1991 Jun;179(6):366-70.

PMID:
2051152
20.

Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.

Stewart JW, Quitkin FM, McGrath PJ, Rabkin JG, Markowitz JS, Tricamo E, Klein DF.

Psychiatry Res. 1988 Aug;25(2):213-22.

PMID:
3051072
Items per page

Supplemental Content

Support Center